Page
%P
-
Article
Open AccessPredicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy
Melanoma patients frequently develop brain metastases. The most widely used score to predict survival is the molGPA based on a mixed treatment of stereotactic radiotherapy (SRT) and whole brain radiotherapy (W...
-
Article
Open AccessCorrection to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy
An amendment to this paper has been published and can be accessed via the original article.
-
Article
Open AccessMRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics
Combination therapy for melanoma brain metastases (MM) using stereotactic radiosurgery (SRS) and immune checkpoint-inhibition (ICI) or targeted therapy (TT) is currently of high interest. In this collective, t...
